
Hosted by BBC Radio 4 · EN
Series that demystifies health issues, separating fact from fiction and bringing clarity to conflicting health advice.

Earlier this summer, there was some incredible progress in cervical cancer. Women who have been vaccinated against the human papillomavirus (HPV) now have an almost zero chance of dying from cervical cancer before the age of 30. But does that mean women will no longer need cervical screening? Dr Jo Morrison, a consultant gynaecological oncologist from Somerset NHS Foundation Trust, joins James Gallagher and resident GP Dr Margaret McCartney to discuss. The government has announced school dinners will soon be overhauled in England, in order to reduce the amount of salt, sugar and fat, and boost the amount of fibre and nutrients offered to schoolchildren. James is joined by Dr Maria Traka, head of the food and nutrition national bioscience research infrastructure at the Quadram Institute in Norwich, to find out what the new dinners will look like. He also pays a visit to the Food Museum in Suffolk, where curator Katherine Bridges takes him on a trip through the decades, to see whether school dinners are healthier than ever. Also, have you seen the buzz surrounding creatine on social media? Gym-goers promise it can help you get stronger and build bigger muscles, but there is also some debate about whether it could boost your brain too. To dig into the science, James chats with Dr Damian Bailey, a professor of physiology and biochemistry at the University of South Wales.Presenter: James Gallagher Producer: Alice Lipscombe-Southwell Editor: Ilan Goodman Production coordinator: Stu Laws Sound engineer: Steve Greenwood

An experimental treatment to “reset” the immune systems of people with autoimmune disease is showing transformative results in early trials. James visits the NIHR Clinical Research Facility in Manchester to meet Kathy. She was diagnosed with lupus just after the birth of her baby and in 2024 became the first person in the UK to try CAR-T therapy as part of a clinical trial. How is she feeling now?We’ll also hear from Kathy’s rheumatologist Professor Ben Parker, who led the trial Kathy took part in and explains how the therapy works, the astonishing early results - and whether the effects on the immune system are long lasting.Also this week, James visits the London School of Hygiene and Tropical Medicine to meet some lab-grown British mosquitoes and find out whether they’re out to get us for longer periods of the year and how worried we should be about the threat of disease, with medical entomologist Dr Mojca Kristan and virologist Professor Roger Hewson. And we look at the latest online trend of “spermmaxxing” with urologist Professor Vaibhav Modgil. Why are men trying to optimise their sperm by dipping their testicles in iced water and abstaining from porn - and is there any evidence for these tactics?Presenter: James Gallagher Producer: Gerry Holt Editor: Ilan Goodman Production coordinator: Stu Laws Sound engineer: Mary Stone

A new non-hormonal drug has been approved to treat menopausal hot flushes. It works by regulating the body's cooling signals and is now available on the NHS in England for those who cannot use hormone replacement therapy. Before delving into the evidence with resident GP Dr Margaret McCartney, James finds out what it feels like to have a hot flush.Also this week, James chats to Dr Manjula Meda, a microbiologist who is spearheading a radical new project. She has found that water systems in hospitals may be a breeding ground for antimicrobial resistance, and is tackling this by removing the sinks from wards. Is it effective and safe?Finally, we all do it, but we don't like discussing it... Farting. James speaks to the University of Maryland's Professor Brantley Hall, who has developed a 'fart detector' that can measure emissions to get a better understanding of gut health. And James gets the chance to attach one to his pants for three days. For science, of course.Presenter: James Gallagher Producer: Alice Lipscombe-Southwell and Gerry Holt Content editor: Ilan Goodman Production coordinator: Stuart Laws Inside Health was made by the BBC’s Audio Science Unit in collaboration with The Open University.

Little over a week on from the first meningitis cases in Canterbury, many crucial questions remain. So this week we're taking an in-depth look at those questions and what we’ve learnt from this outbreak - and could it happen again?James also hears from author Michael Rosen whose son Eddie died from meningitis aged 18 about just how quickly the disease struck and how he deals with his grief. And would you trust health advice from an AI chatbot? We hear from someone who regularly turns to ChatGPT and from GP Dr Margaret McCartney about her concerns.Presenter: James Gallagher Producer: Gerry Holt Content editor: Ilan Goodman Production coordinator: Stuart Laws Studio engineer: Donald MacDonaldInside Health was made by the BBC’s Audio Science Unit in collaboration with The Open University.

More than 30,000 people are being contacted in the Canterbury area regarding the outbreak of bacterial meningitis in Kent. Two people have died, and others are seriously ill. James Gallagher speaks with immunologist Sir Andrew Pollard about the disease, and finds out what could have caused the outbreak.That’s the major headline from the UK. But more broadly, for the last few weeks the news has been dominated by the situation in the Middle East. James speaks with Dr Antoine Abou Fayad, a microbiologist and medicinal chemist based in Beirut, Lebanon. He reveals that war, just like the ongoing conflict in the Middle East, provides the perfect storm to accelerate the spread of multidrug-resistant infections. And nobody is safe. And finally, James finds out about an ongoing trial at the University of Exeter, where interactive computer games are being used by stroke patients to improve their recovery. And, of course, James has a go himself!Presenter: James Gallagher Producer: Alice Lipscombe-Southwell Researcher: Tom Hunt Editor: Ilan Goodman

There have been nearly 200 cases of measles in the UK so far this year.Measles can be prevented with vaccines - but the proportion of children being immunised is declining across the UK, particularly in parts of London.James visits Hackney, which has one of the lowest vaccination rates in the country, to find out why and to see what is happening to tackle this issue.And have you tried an adaptogenic drink? They claim to relax the mind, without giving you a boozy hangover. James samples some in the lab and then gets behind the wheel of a simulator to see what it does to his driving skills…Presenter: James Gallagher Producer: Gerry Holt Researcher: Thomas Hunt Editor: Ilan Goodman Production coordinator: Stuart Laws Sound engineer: Giles AspenInside Health was made by the BBC’s Audio Science Unit in collaboration with The Open University.

Penis fillers were an unexpected talking point at the recent Winter Olympics after claims that male ski jumpers were having them to improve performance.So this week we’re digging into the UK’s penis filler industry.James visits a private clinic in Manchester to hear about about the procedure, which involves hyaluronic acid being injected to temporarily increase penis girth. He meets Jason, who had his first penis filler five months’ ago, and he explains why he wanted it and how he weighed up the risks versus the benefits.James also chats to an NHS surgeon who says increasing numbers of men are seeking out the procedure - and he is dealing with the consequences when it goes wrong.Also this week, why is aspirin in short supply? Presenter: James Gallagher Producer: Gerry Holt Editor: Ilan Goodman Production coordinator: Stuart Laws Sound engineer: Emma Harth The show was made by the BBC’s Audio Science Unit in collaboration with The Open University.

ME – also known as Chronic Fatigue Syndrome – has long been one of medicine’s most perplexing conditions. With no definitive diagnostic test and a legacy of scepticism in parts of the medical community, patients have often struggled to be believed. But a surge of new research may finally be shifting the landscape. The emergence of Long COVID – a condition with striking similarities to ME – has accelerated scientific interest and opened new lines of inquiry into the underlying biology of both illnesses.In this episode, James Gallagher speaks to Dr Chris Ponting about the latest DecodeME results, which point to a strong genetic component to ME. And Professor Rosemary Boyton outlines the ambition behind the new Rosetta Stone study, designed to build a detailed evidence base of shared biomarkers across ME and Long COVID. James also hears from Catherine and Jo, who have lived with ME for many years. They describe their diagnostic journeys and how they manage their symptoms in their daily lives. Presenter: James Gallagher Producer: Alice Lipscombe-Southwell Researcher: Tom Hunt Editors: Erika Wright and Ilan Goodman

Over 1.5million adults in the UK tried weight loss drugs in 2024-25. Many swear by them, but they have been associated with side effects including nausea and, in some cases, extremely painful gallstones. But what does the evidence actually tell us, and what is the wider impact on the way we view our bodies in society?James Gallagher is joined by Professor of Cardiometabolic Medicine at the University of Glasgow Naveed Sattar, Dr Beverley O’Hara, Lecturer in Public Health Nutrition at Leeds Beckett University, and Dr Margaret McCartney, resident Inside Health GP. They discuss what the evidence tells us about the potential known side effects of these weight loss drugs, and the potential impact their use has on our view of obesity as a society. We also hear from Sarah Le Brocq, who has struggled with obesity all her adult life and has been on these drugs for the past 2-3 years about her experiences. Margaret McCartney has no conflicts of interest to declare.Beverley O’Hara has no conflicts of interest to declare. She has 2 roles with the Association for the Study of Obesity (voluntary academic positions).Naveed Sattar has consulted for and/or received speaker honoraria from AbbVie, Amgen, AstraZeneca, Boehringer Ingelheim, Carmot Therapeutics, Eli Lilly, Gan & Lee, GlaxoSmithKline, Hanmi Pharmaceuticals, Kailera, Mass Medicines, Menarini-Ricerche, Metsera, Novo Nordisk, Pfizer, Regeneron, Roche, UCB Pharma, and Verdiva Bio; and received grant support paid to his University from AstraZeneca, Boehringer Ingelheim, Novartis, and Roche.Presenter: James Gallagher Producer: Hannah Fisher Researcher: Tom Hunt Production coordinator: Stuart Laws Content Editor: Ilan Goodman

Dentistry is high on the public and political agenda. There have been dozens of headlines about access to NHS dentistry, with some people having to travel huge distances to find a dentist, or being put onto long waiting lists to get an NHS appointment. In this episode of Inside Health, James Gallagher is joined by chairman of the British Dental Association Eddie Crouch, the Oral Health Foundation's Dr Rachael England, and consultant oral surgeon Tom Thayer. Together, they drill into the issues surrounding NHS dentistry. Along the way, they discuss possible solutions, whether contract reforms will help, and the potential future of dentistry in the UK. Presenter: James Gallagher Producers: Alice Lipscombe-Southwell and Thomas Hunt Production coordinator: Stuart Laws Content editor: Ilan Goodman